Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies

PURPOSE: To assess the pharmacokinetics and safety of hydrochloride ophthalmic solution 0.77% olopatadine from 2 independent (Phase I and Phase III, respectively) clinical studies in healthy subjects. MATERIALS AND METHODS: The Phase I, multicenter, randomized (2:1), vehicle-controlled study was con...

Descripción completa

Detalles Bibliográficos
Autores principales: Meier, Edward, Narvekar, Abhijit, Iyer, Ganesh R, DuBiner, Harvey B, Vutikullird, Apinya, Wirta, David, Sall, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391828/
https://www.ncbi.nlm.nih.gov/pubmed/28435218
http://dx.doi.org/10.2147/OPTH.S126690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391828/
https://www.ncbi.nlm.nih.gov/pubmed/28435218
http://dx.doi.org/10.2147/OPTH.S126690

Ejemplares similares